Abstract
Since the discovery of the abnormal response of cells from ataxia-telangiectasia (A-T) homozygotes to ionising radiation and free radical-generating chemicals (reviewed in Bridges and Harnden, 1982) the response of cells from heterozygotes has been investigated with many procedures (summarised by Weeks et al., 1991). Most techniques are able to detect a shift in the average response of heterozygote cells compared with normals but with considerable overlap between the two groups. The assay that has been reported to provide the best discrimination has been devised by K.K. Sanford and colleagues at the National Cancer Institute (NCI) and involves X-irradiating cells in the G2 phase of the cell cycle and quantifying radiation-induced chromosome damage in these cells when they undergo mitosis. In comparisons between 52 controls and 29 obligate heterozygotes, 50 of the controls had lower chromosome aberration frequencies than any of the heterozygotes. These studies were on cultured skin fibroblasts (20 heterozygotes and 17 controls for which there was complete discrimination; Parshad et al., 1985; Shiloh et al., 1986; Shiloh et al., 1989) and peripheral blood lymphocytes (9 heterozygotes and 35 controls with overlap of 2 controls; Sanford and Parshad, 1990).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Bridges BA, Harnden DG (eds) (1982) Ataxia-telangiectasia: A cellular and molecular link between cancer, neuropathology and immune deficiency. John Wiley, Chichester.
Burnet NG, Nyman J, Turesson I, Wurm MD, Yarnold JR, Peacock JH (1992) Potential for improving tumour cure rates by predicting normal tissue tolerance to radiotherapy from in vitro cellular radiation sensitivity. Lancet i: 1570–1571.
Cunliffe PN, Mann JR, Cameron AH, Roberts KD, Ward HWC (1975) Radiosensitivity in ataxia telangiectasia. Br J Radiol 48: 374–376.
Elyan SAG, West CML, Roberts SA, Hunter RD (1993) Reproducible ranking of human T-lymphocyte intrinsic radiosensitivity. Submitted to Int J Radiat Biol.
Fenech M, Morley AA (1985) Solutions to the kinetic problem in the micronucleus assay. Cytobio 43: 233–246.
Gotoff SP, Amirnokri E, Liebnor EJ (1967) Ataxia-telangiectasia, neoplasia, untoward response to X-irradiation and tuberous schlerosis. Am J Dis Child 114: 617–627.
James SE, Arlett CF, Green MHL, Bridges BA (1983) Radiosensitivity of human T-lymphocytes proliferating in long term culture. Int J Radiat Biol 44: 417–422.
Norman A, Kagan AR, Chan SL (1988) The importance of genetics for the optimisation of radiation therapy. Am J Clin Oncol 11: 84–88.
Parshad R, Sanford KK, Jones GM (1985) Chromosomal radiosensitivity during the G2 cell-cycle period of skin fibroblasts from individuals with familial cancer. Proc Natl Acad Sci USA 82: 5400–5403.
Paterson MC, MacFarlane SJ, Gentner NE, Smith BP (1985) Cellular hypersensitivity to chronic y-radiation in cultured fibroblasts from ataxia-telangiectasia heterozygotes. In: Ataxia-telangiectasia: Genetics, neuropathology and immunology of a degenerative disease of childhood. Gatti RA, Swift M (eds) Liss New York 73–87.
Sanford KK, Parshad R (1990) Detection of cancer-prone individuals using cytogenetic response to X-rays. In: Chromosome aberrations, basic and applied aspects. Obe G, Natarajan AT (eds) Springer-Verlag 113–120.
Sanford KK, Parshad R, Green MH, Tarone RE, Tucker MA, Jones GM (1987) Hypersensitivity to G2 chromatid damage in familial dysplastic naevus syndrome. Lancet ii: 1111–1115.
Sanford KK, Parshad R, Gantt R, Tarone RE, Jones GM, Price FM (1989) Factors affecting and signficance of G2 chromatin radiosensitivity in predisposition to cancer. Int J Radiat Biol 55: 963–981.
Scott D, Lyons CY (1979) Homogeneous sensitivity of human peripheral blood lymphocytes to radiation-induced chromosome damage. Nature 278: 756–758.
Scott D, Spreadborough AR, Jones LA (1993) Chromosomal radiosensitivity in G2 lymphocytes as an indicator of cancer predisposition: Experience with the National Cancer Institute technique. In preparation.
Shiloh Y, Parshad R, Frydman M, Sanford KK, Portnoi S, Ziv Y, Jones GM (1989) G2 chromosomal radiosensitivity in families with ataxia-telangiectasia. Hum Genet 84: 15–18.
Shiloh Y, Parshad R, Sanford KK, Jones GM (1986) Carrier detection in ataxia-telangiectasia. Lancet i: 689–690.
Swift M, Morrell D, Cromartic E, Chamberlin AR, Skolnick MH, Bishop DT (1986) The incidence and gene frequency of ataxia-telangiectasia in the United States. Am J Hum Genet 39: 573–583.
Swift M, Morrell D, Massey RB, Chase CL (1991) Incidence of cancer in 161 families affected by ataxia-telangiectasia. New Eng J Med 325: 1831–1836.
Taylor AMR, Harnden DG, Arlett CF, Harcourt SA, Lehman AR, Stevens S, Bridges BA (1975) Ataxia-telangiectasia: a human mutation with abnormal radiation sensitivity. Nature 258: 427–429.
Weeks DE, Paterson MC, Lange K, Andrais B, Davis RC, Yoder F, Gatti RA (1991) Assessment of chronic γ-radiosensitivity as an in vitro assay for heterozygote identification in ataxia-telangiectasia. Radiat Res 128: 90–99.
Weincke JR, Wara DW, Little JB, Kelsey KT (1992) Heterogeneity in the clastogenic response to X-rays in lymphocytes from ataxia-telangiectasia heterozygotes and controls. Cancer Causes and Control 3: 237–245
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Scott, D., Jones, L.A., Elyan, S.A.G., Spreadborough, A., Cowan, R., Ribiero, G. (1993). Identification of A-T heterozygotes. In: Gatti, R.A., Painter, R.B. (eds) Ataxia-Telangiectasia. NATO ASI Series, vol 77. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78278-7_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-78278-7_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-78280-0
Online ISBN: 978-3-642-78278-7
eBook Packages: Springer Book Archive